Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse

By Vicari Alain  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 615-628

Springer Publishing Company

Access to resources Recommend Favorite

Muscarinic Activation Enhances the Anti-proliferative Effect of Paclitaxel in Murine Breast Tumor Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 8, 2013-10 ,pp. : 1273-1279

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis

By Wu Kai-Da   Zhou Li   Burtrum Douglas   Ludwig Dale   Moore Malcolm  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 343-357

Springer Publishing Company

Access to resources Recommend Favorite

Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts

By          

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 923-928

Spandidos Publications

Access to resources Recommend Favorite

Dose-dense Vinorelbine and Paclitaxel with Granulocyte Colony-stimulating Factor in Metastatic Breast Cancer Patients: Anti-tumor Activity and Peripheral Blood Progenitor Cell Mobilization Capability

By Ballestrero Alberto   Montemurro Filippo   Gonella Roberta   Capaldi Antonio   Danova Marco   Friedman Daniele   Puglisi Maria   Aglietta Massimo   Patrone Franco  

Breast Cancer Research and Treatment, Vol. 82, Iss. 3, 2003-12 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite